Suchergebnisse - "Pala, Daniele"

PubPharm (46)

1

Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension

enthalten in: European journal of pharmacology | 2019

von Cantoni, S. | Cavalli, S. | Pastore, F. | +8

2

Spatial Enablement to Support Environmental, Demographic, Socioeconomics, and Health Data Integration and Analysis for Big Cities : A Case Study With Asthma Hospitalizations in New York City

enthalten in: Frontiers in medicine | 2019

von Pala, D. | Pagán, J. | Parimbelli, E. | +3

3

Atropisomerism and Conformational Equilibria : Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs

enthalten in: Journal of medicinal chemistry | 2017

von Lodola, A. | Bertolini, S. | Biagetti, M. | +10

4

Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8

enthalten in: Journal of chemical information and modeling | 2017

von Callegari, D. | Lodola, A. | Pala, D. | +4

ErratumIn: J Chem Inf Model. 2017 Feb 27;57(2):386. - PMID 28151658

5

Correction to Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8

enthalten in: Journal of chemical information and modeling | 2017

von Callegari, D. | Lodola, A. | Pala, D. | +4

ErratumFor: J Chem Inf Model. 2017 Feb 27;57(2):159-169. - PMID 28080056

6

Metadynamics for Perspective Drug Design : Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor

enthalten in: Journal of medicinal chemistry | 2017

von Incerti, M. | Russo, S. | Callegari, D. | +10

7

Free-energy studies reveal a possible mechanism for oxidation-dependent inhibition of MGL

enthalten in: Scientific reports | 2016

von Scalvini, L. | Vacondio, F. | Bassi, M. | +6

8

Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase

enthalten in: Glycobiology | 2016

von Pala, D. | Rivara, S. | Mor, M. | +4

9

Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists : From Simulation to Experiment and Return

enthalten in: Chemistry (Weinheim an der Bergstrasse, Germany) | 2016

von Russo, S. | Callegari, D. | Incerti, M. | +11

10

Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis

enthalten in: Biochemical pharmacology | 2016

von Giorgio, C. | Russo, S. | Incerti, M. | +10

1
2
3
4
5
Nächster »
[5]